Take-homes from new FDA NEJM stem cell piece including surprises

Peter-Marks-Scott-Gottlieb-FDA

FDA Commissioner Scott Gottlieb and CBER Director, Peter Marks, have just published a new piece on stem cells and regenerative medicine in the New England Journal of Medicine (NEJM). What are the core points here and what can we learn from reading between the lines a bit? There are some expected things and then some …

Take-homes from new FDA NEJM stem cell piece including surprises Read More »